AYE vs NIVABUPA: Stock Comparison

AYE FINANCE vs NIVA BUPA HEALTH INS CO LUpdated 2 Sept 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. AYE FINANCE shows a lower P/E, a higher ROE and a higher ROCE, while NIVA BUPA HEALTH INS CO L shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AYE leads 6; NIVABUPA leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AYENIVABUPA

Valuation lens

What price are you paying?

Market CapContext only
₹4,232 Cr
₹14,923 Cr
P/E RatioAYE has the lower reading
21.91x
116.18x
P/B RatioAYE has the lower reading
1.68x
4x
EPSAYE has the higher reading
₹3.02
₹1.87
Book ValueContext only
₹102.63
₹23.73
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NIVABUPA is the larger company
₹14,923 Cr vs ₹4,232 Cr
P/E Ratio
AYE has a lower P/E
21.91x vs 116.18x
P/B Ratio
AYE has a lower P/B
1.68x vs 4x
EPS
AYE has higher earnings per share
₹3.02 vs ₹1.87
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
ROE
AYE has a higher ROE
13.57% vs 0%
ROCE
AYE has a higher ROCE
12.98% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAYENIVABUPA
SectorFinancial Services
IndustryGeneral Insurance

Price

MetricAYENIVABUPA
Live Price₹171.34₹80.73
Day Change-0.21%-1.91%
Volume17.7 L3.66 L
52-Week High₹197.29₹91.4
52-Week Low₹88.22₹67.5
Distance from 52W High-13.15%-11.67%

Valuation

MetricAYENIVABUPA
Market Cap₹4,232 Cr₹14,923 Cr
P/E Ratio21.91x116.18x
P/B Ratio1.68x4x
EPS₹3.02₹1.87
Book Value₹102.63₹23.73
Dividend Yield0%0%

Growth

MetricAYENIVABUPA
Revenue Growth (TTM YoY)0%26.8%
EPS Growth (TTM YoY)0%90.2%
Qtr Sales Growth-9.66%
Qtr Profit Growth-13.28%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricAYENIVABUPA
ROE13.57%0%
ROCE12.98%0%
Net Margin10.67%4.34%
Operating Margin46.44%
Debt to Equity1.56x0.07x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAYENIVABUPA
Promoter Holding0.73%0%
FII Holding15.7% 2.96 pp12.09% 1.49 pp
DII Holding19.75% 1.36 pp16.17% 0.32 pp
Public Holding63.81% 1.79 pp16.44% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AYE FINANCE and NIVA BUPA HEALTH INS CO L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.